109 related articles for article (PubMed ID: 28623138)
1. HP1α is highly expressed in glioma cells and facilitates cell proliferation and survival.
Lai X; Deng Z; Guo H; Zhu X; Tu W
Biochem Biophys Res Commun; 2017 Aug; 490(2):415-422. PubMed ID: 28623138
[TBL] [Abstract][Full Text] [Related]
2. HP1α is highly expressed in glioma cells and facilitates cell proliferation and survival.
Lai X; Deng Z; Guo H; Zhu X; Tu W
Cancer Biomark; 2017 Dec; 20(4):453-460. PubMed ID: 28946550
[TBL] [Abstract][Full Text] [Related]
3. Role of histone lysine methyltransferases SUV39H1 and SETDB1 in gliomagenesis: modulation of cell proliferation, migration, and colony formation.
Spyropoulou A; Gargalionis A; Dalagiorgou G; Adamopoulos C; Papavassiliou KA; Lea RW; Piperi C; Papavassiliou AG
Neuromolecular Med; 2014 Mar; 16(1):70-82. PubMed ID: 23943221
[TBL] [Abstract][Full Text] [Related]
4. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment.
Allan RS; Zueva E; Cammas F; Schreiber HA; Masson V; Belz GT; Roche D; Maison C; Quivy JP; Almouzni G; Amigorena S
Nature; 2012 Jul; 487(7406):249-53. PubMed ID: 22763435
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of HP1α suppresses proliferation of cholangiocarcinoma by restoring SFRP1 expression.
Cheng W; Tian L; Wang B; Qi Y; Huang W; Li H; Chen YJ
Oncotarget; 2016 Jul; 7(30):48107-48119. PubMed ID: 27385214
[TBL] [Abstract][Full Text] [Related]
6. A model of dynamic stability of H3K9me3 heterochromatin to explain the resistance to reprogramming of differentiated cells.
Jehanno C; Flouriot G; Le Goff P; Michel D
Biochim Biophys Acta Gene Regul Mech; 2017 Feb; 1860(2):184-195. PubMed ID: 27876670
[TBL] [Abstract][Full Text] [Related]
7. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
8. EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas.
Erfani P; Tome-Garcia J; Canoll P; Doetsch F; Tsankova NM
Epigenetics; 2015; 10(6):496-507. PubMed ID: 25996283
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.
Dai B; Hu Z; Huang H; Zhu G; Xiao Z; Wan W; Zhang P; Jia W; Zhang L
Biochem Biophys Res Commun; 2014 Nov; 454(1):221-7. PubMed ID: 25450384
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell Depletion by Global Disorganization of the H3K9me3 Epigenetic Marker in Aging.
Mendelsohn AR; Larrick JW
Rejuvenation Res; 2015 Aug; 18(4):371-5. PubMed ID: 26160351
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of myogenic gene expression by heterochromatin protein 1 alpha.
Sdek P; Oyama K; Angelis E; Chan SS; Schenke-Layland K; MacLellan WR
PLoS One; 2013; 8(3):e58319. PubMed ID: 23505487
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of G9a inhibitor BIX‑01294 acting on U251 glioma cells.
Guo AS; Huang YQ; Ma XD; Lin RS
Mol Med Rep; 2016 Nov; 14(5):4613-4621. PubMed ID: 27748874
[TBL] [Abstract][Full Text] [Related]
13. The local density of H3K9me3 dictates the stability of HP1α condensates-mediated genomic interactions.
Feng Y; Guo L; Yang C; Zheng H; Xiao X; Ma H
J Genet Genomics; 2023 Oct; 50(10):776-785. PubMed ID: 37116579
[TBL] [Abstract][Full Text] [Related]
14. Beyond the histone tale: HP1α deregulation in breast cancer epigenetics.
Vad-Nielsen J; Nielsen AL
Cancer Biol Ther; 2015; 16(2):189-200. PubMed ID: 25588111
[TBL] [Abstract][Full Text] [Related]
15. Visualization of the dynamic interaction between nucleosomal histone H3K9 tri-methylation and HP1α chromodomain in living cells.
Sasaki K; Suzuki M; Sonoda T; Schneider-Poetsch T; Ito A; Takagi M; Fujishiro S; Sohtome Y; Dodo K; Umehara T; Aburatani H; Shin-Ya K; Nakao Y; Sodeoka M; Yoshida M
Cell Chem Biol; 2022 Jul; 29(7):1153-1161.e5. PubMed ID: 35728598
[TBL] [Abstract][Full Text] [Related]
16. [Aberrant expression of sox2 gene in malignant gliomas].
Volnitskiĭ AV; Semenova EV; Shtam TA; Kovalev RA; Filatov MV
Tsitologiia; 2014; 56(7):504-10. PubMed ID: 25696994
[TBL] [Abstract][Full Text] [Related]
17. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
[TBL] [Abstract][Full Text] [Related]
18. HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma.
Han L; Liu D; Li Z; Tian N; Han Z; Wang G; Fu Y; Guo Z; Zhu Z; Du C; Tian Y
PLoS One; 2015; 10(11):e0142387. PubMed ID: 26565624
[TBL] [Abstract][Full Text] [Related]
19. MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A.
Shang C; Hong Y; Guo Y; Liu YH; Xue YX
Med Sci Monit; 2014 Dec; 20():2571-7. PubMed ID: 25481483
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic aspects of HP1 exchange kinetics in apoptotic chromatin.
Legartová S; Jugová A; Stixová L; Kozubek S; Fojtová M; Zdráhal Z; Lochmanová G; Bártová E
Biochimie; 2013 Feb; 95(2):167-79. PubMed ID: 23023195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
